Effect of hydrocortisone on the production and glycosylation of an Fc‐fusion protein in CHO cell cultures

Glucocorticoids are known to modulate various cellular functions such as cell proliferation, metabolism, glycosylation, and secretion of many proteins. We tested the effect of hydrocortisone (HC) on cell growth, viability, metabolism, protein production, and glycosylation of an Fc‐protein expressing Chinese hamster ovary (CHO) cell culture. HC extended cell viability but impaired cell growth. The inhibitory effect on cell growth was dose‐dependent and decreased when the glucocorticoid addition was delayed. When HC was added after 2 or 3 days of culture, an increase in glutamate consumption was observed, which was reversed by the glucocorticoid receptor antagonist mifepristone (Mif). Titer and specific productivity increased in the presence of HC. The increase in titer was only slightly reversed by Mif. On the other hand, Mif by itself induced an increase in titer to a level comparable to or higher than HC. Protein glycosylation was altered by the glucocorticoid in a dose‐ and time‐dependent manner, with a shift to more acidic bands, which correlated with an increase in sialic acid moieties. This increase, which was not linked to a decrease in extracellular sialidase activity in HC‐treated cultures, was reversed by Mif. Predictive models based on design of experiments enabled the definition of optimal conditions for process performance in terms of viability and titer and for the quality of the Fc‐fusion protein in terms of glycosylation. The data obtained suggest a use of glucocorticoids for commercial production of Fc‐fusion proteins expressed in CHO cells. © 2012 American Institute of Chemical Engineers Biotechnol. Prog., 2012

[1]  J. Bertoglio,et al.  Structure-activity relationships in glucocorticoid-induced apoptosis in T lymphocytes. , 1995, Biochemical pharmacology.

[2]  S. Herzig,et al.  Role of glucocorticoids and the glucocorticoid receptor in metabolism: Insights from genetic manipulations , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  A. Shafferman,et al.  Hierarchy of Post-translational Modifications Involved in the Circulatory Longevity of Glycoproteins , 2000, The Journal of Biological Chemistry.

[4]  Nigel Jenkins,et al.  Getting the glycosylation right: Implications for the biotechnology industry , 1996, Nature Biotechnology.

[5]  Gyun Min Lee,et al.  Effect of low culture temperature on specific productivity, transcription level, and heterogeneity of erythropoietin in Chinese hamster ovary cells. , 2003, Biotechnology and bioengineering.

[6]  Lucia Baldi,et al.  Recombinant therapeutic protein production in cultivated mammalian cells: current status and future prospects. , 2008, Drug discovery today. Technologies.

[7]  Duk Jae Oh,et al.  Effects of Supplementation of Various Medium Components on Chinese Hamster Ovary Cell Cultures Producing Recombinant Antibody , 2005, Cytotechnology.

[8]  I. Miyamori,et al.  Effects of brief glucocorticoid exposure on growth of vascular smooth muscle cells in culture. , 1998, Biochemical and biophysical research communications.

[9]  A. Canellada,et al.  The immunomodulatory action of dexamethasone on monoclonal antibody-producing hybridoma cells. , 2002, Hybridoma and hybridomics.

[10]  D. Gilroy,et al.  Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells , 2002, British journal of pharmacology.

[11]  G. Ashwell,et al.  The asialoglycoprotein receptor: properties and modulation by ligand. , 1989, Progress in clinical and biological research.

[12]  P. Barnes,et al.  Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.

[13]  R. Kaufman,et al.  The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins , 1987, The Journal of cell biology.

[14]  H. Kozutsumi,et al.  Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  F Gòdia,et al.  Improvement of CHO Cell Culture Medium Formulation: Simultaneous Substitution of Glucose and Glutamine , 2000, Biotechnology progress.

[16]  E. Falkenstein,et al.  Multiple actions of steroid hormones--a focus on rapid, nongenomic effects. , 2000, Pharmacological reviews.

[17]  M. Butler,et al.  The Effect of Cell Culture Parameters on Protein Glycosylation , 2002 .

[18]  Z. Li,et al.  Sialylation enhancement of CTLA4‐Ig fusion protein in Chinese hamster ovary cells by dexamethasone , 2010, Biotechnology and bioengineering.

[19]  B. O’Malley,et al.  Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Danny Chee Furng Wong,et al.  Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures. , 2005, Biotechnology and bioengineering.

[21]  L. Nathanson,et al.  In vitro growth inhibition of human malignant melanoma cells by glucocorticoids. , 1983, Cancer research.

[22]  M. Butler,et al.  Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. , 2000, Biotechnology and bioengineering.

[23]  D. Kompala,et al.  Increased production of a secreted glycoprotein in engineered CHO cells through amplification of a transcription factor , 2004, Cytotechnology.

[24]  Kai Griebenow,et al.  Effects of glycosylation on the stability of protein pharmaceuticals. , 2009, Journal of pharmaceutical sciences.

[25]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[26]  P. Delannoy,et al.  Transcriptional induction of beta-galactoside alpha-2,6-sialyltransferase in rat fibroblast by dexamethasone. , 1993, European journal of biochemistry.

[27]  Z. Li,et al.  Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.

[28]  F. Lasne,et al.  Caspase activation, sialidase release and changes in sialylation pattern of recombinant human erythropoietin produced by CHO cells in batch and fed-batch cultures , 2006, Cytotechnology.

[29]  S. London,et al.  Mifepristone (RU486): a review. , 1997, Fertility and sterility.

[30]  T. Boone,et al.  Role of glycosylation on the secretion and biological activity of erythropoietin. , 1992, Biochemistry.

[31]  M. Matzuk,et al.  The Role of the Asparagine-linked Oligosaccharides of the a Subunit in the Secretion and Assembly of Human Chorionic Gonadotropin , 1988 .

[32]  R. Wait,et al.  Relationships between the N‐glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures , 2003, British journal of haematology.

[33]  C. Borek,et al.  Suppression of DNA synthesis in hepatoma cells exposed to glucocorticoid hormone in vitro. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Didier-Bazès,et al.  Glucocorticoid upregulation of glutamate dehydrogenase gene expression in vitro in astrocytes. , 1996, Brain research. Molecular brain research.

[35]  P. J. Barnes,et al.  Corticosteroid effects on cell signalling , 2006, European Respiratory Journal.

[36]  P. Højrup,et al.  The Function of the Human Interferon-β1a Glycan Determined in Vivo , 2008, Journal of Pharmacology and Experimental Therapeutics.

[37]  S. Elliott,et al.  Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. , 2005, Journal of pharmaceutical sciences.

[38]  G. Burton,et al.  New lead compounds in the search for pure antiglucocorticoids and the dissociation of antiglucocorticoid effects , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[39]  Martin Gawlitzek,et al.  Identification of cell culture conditions to control N‐glycosylation site‐occupancy of recombinant glycoproteins expressed in CHO cells , 2009, Biotechnology and bioengineering.

[40]  Roland Schauer,et al.  Achievements and challenges of sialic acid research , 2000, Glycoconjugate Journal.

[41]  J. Jonklaas,et al.  The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values , 2007, Steroids.

[42]  M. Butler,et al.  Enhanced Production of Monomeric Interferon‐β by CHO Cells through the Control of Culture Conditions , 2008, Biotechnology progress.

[43]  Y. Ahn,et al.  Development of a serum-free medium for the production of erythropoietin by suspension culture of recombinant Chinese hamster ovary cells using a statistical design. , 1999, Journal of biotechnology.

[44]  M B Sliwkowski,et al.  Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms. , 2000, Biotechnology and bioengineering.

[45]  R. Horstkorte,et al.  Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway. , 2009, Journal of pharmaceutical sciences.

[46]  W. Rom,et al.  Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. , 2002, American journal of respiratory cell and molecular biology.

[47]  K. Yamamoto,et al.  Glucocorticoid-regulated glycoprotein maturation in wild-type and mutant rat cell lines , 1986, The Journal of cell biology.

[48]  J. Cidlowski,et al.  The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. , 2002, Molecular endocrinology.

[49]  Mi-Sook Lee,et al.  Identification of the functional domain of glucocorticoid receptor involved in RU486 antagonism , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[50]  J. Lau,et al.  Regulation of beta-galactoside alpha 2,6-sialyltransferase gene expression by dexamethasone. , 1989, The Journal of biological chemistry.

[51]  Chun Cheng,et al.  Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line , 2009, Brain Research.

[52]  S. R. Fox,et al.  Maximizing interferon‐γ production by chinese hamster ovary cells through temperature shift optimization: Experimental and modeling , 2004, Biotechnology and bioengineering.

[53]  B. B. Gupta,et al.  Molecular mechanisms of glucocorticoid action , 2002 .

[54]  R. Farkas,et al.  Hormonal control of protein glycosylation: role of steroids and related lipophilic ligands. , 2004, Endocrine regulations.

[55]  P. Gray,et al.  Expression of FSH in CHO cells. II. Stimulation of hFSH expression levels by defined medium supplements , 1995, Cytotechnology.

[56]  A. Lancha,et al.  Glucocorticoids: Extensive physiological actions modulated through multiple mechanisms of gene regulation , 2010, Journal of cellular physiology.

[57]  C. Goochee,et al.  Glycosidase Activities in Chinese Hamster Ovary Cell Lysate and Cell Culture Supernatant , 1993, Biotechnology progress.